Oryzon Genomics is proud to announce its participation as a sponsor of the first-ever Phelan-McDermid syndrome (PMS) burden of illness study. The study is led by CureShank, a research advocacy organiz...
Read more
The aim of this strategic agreement is to promote initiatives with significant biomedical potential which, despite their innovative value, lack sufficient financial resources in their early stages of ...
Read more
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates how a CAR-T therapy designed at the center c...
Read more
The center is participating in an international clinical trial that seeks to improve patients' quality of life by addressing sleep, communication and motor disorders.
Read more
Basado en abstracciones matemáticas de algunos procesos neuronales, explica cómo funcionan las neuronas de la corteza visual
Read more
El test sanguíneo MAP-AD® de la compañía ADmit Therapeutics, spin-off del IDIBELL, con el Hospital de Bellvitge como centro coordinador clínico, logra un hito regulatorio con el marcado CE y abre...
Read more
The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.
Read more
La comunicación clínica efectiva, por tanto, no es solo una herramienta operativa, sino un factor estratégico en la gestión de ensayos clínicos. Las CROs que integran enfoques centrados en el p...
Read more
The study demonstrates how the MAF Test®, which stratifies early-stage breast cancer patients by MAF gene status to guide adjuvant bisphosphonate therapy, delivers meaningful economic value across mu...
Read more
El cambio climático está aumentando los riesgos de aflatoxinas en los cultivos europeos y que existen lagunas de estandarización que obstaculizan una buena evaluación del riesgo y la adaptación. ...
Read more
Las infecciones por gripe alteran la microbiota pulmonar y potencian la aparición de patógenos oportunistas
Read more
Batea Oncology has developed GlioHook, an innovative medical device implanted during surgery that captures residual tumor cells responsible for relapse and makes them more sensitive to standard radiot...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
